LXEO NASDAQ

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.6%), Lexeo Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $6.8M against a stock market value of $221.6M.
Distance to default 5.64 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.4M (short-term plus half of long-term), stock volatility 71.7%; Altman Z'' 9.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.